Now that pharmacological treatments for Alzheimer's Disease are available, clinicians, purchasers of services, pharmacists, health economists, sufferers and carers all need to know the outcomes of treatment and how these can best be measured. This book considers outcome measures relevant for Alzheimer's disease, identifies suitable assessment tools and considers the relative merits of each of these.